TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Vida Världen Vaccin AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
3,933
|
2,750
|
1,645 |
Financial expenses |
11
|
0
![]() |
0 |
Earnings before taxes |
-47
|
45
|
-43 |
EBITDA |
-37
|
45
|
-43 |
Total assets |
989
|
900
|
1,114 |
Current assets |
989
|
900
|
1,114 |
Current liabilities |
239
|
104
|
59 |
Equity capital |
750
|
796
|
1,055 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
75.8%
|
88.4%
|
94.7% |
Turnover per employee |
1,966
|
1,375
|
822 |
Profit as a percentage of turnover |
-1.2%
|
1.6%
|
-2.6% |
Return on assets (ROA) |
-3.6%
|
5.0%
|
-3.9% |
Current ratio |
413.8%
|
865.4%
|
1888.1% |
Return on equity (ROE) |
-6.3%
|
5.7%
|
-4.1% |
Change turnover |
1,183
|
1,105
|
-639 |
Change turnover % |
43%
|
67%
|
-28% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.